USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Allergan Holdings France S.a.s.

USPTO PatentsView assignee record - 6 granted patents across 12 technology areas, active 2016–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

14.5

Avg claims per patent

-80%

5-year filing velocity

The verdict

Allergan holds 6 US patents across 12 technology areas, rank #38,610 of 50,000 tracked assignees.

#38,610
of 50,000 US assignees by volume: Top 76%
by Innovation Score (27.7/100): 14.5
avg claims per patent: -80%
filing velocity, last 5 yrs

Portfolio overview

Allergan Holdings France S.a.s. has been granted 6 US utility patents between 2016 and 2021, placing Allergan Holdings France S.a.s. at rank #38,610 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.5 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a Foreign Corporation, Allergan Holdings France S.a.s. is one of the more focused assignees in the PatentsView dataset. By volume, Allergan sits between ALFA Laval Vicarb SAS (6 patents, rank #38,606) and Alpao (6 patents, rank #38,614) - the closest US assignees by grant volume. The composite Innovation Score of 27.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 5 in the 2015–2019 window, a -80% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Allergan Holdings France S.a.s.'s 14.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Allergan Holdings France S.a.s. against peers pursuing similar technology classes.

ALFA Laval Vicarb…

6
Algolux

6
Alibaba Technolog…

6
Alioscopy

6
Alliance Machine…

6
ALMA

6
Almalence

6
Alpao

6
Allergan Holdings… ◀

6

What this shows Allergan holds 6 patents at rank #38,610, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Allergan

By rank, the assignees closest to #38,610 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in Allergan's primary technology class.

Allergan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

28 Top 76% higher than 24% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Allergan Holdings France S.a.s. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	16.7%
2018	2	33.3%
2019	2	33.3%
2021	1	16.7%

Which technologies does Allergan Holdings France S.a.s. patent most?

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 5

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 4

C08B - POLYSACCHARIDES; DERIVATIVES THEREOF 4

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 4

A61Q - SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS 4

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 4

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 4

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 4

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 4

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 2

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 2

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 2

Top 12 of 12 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#38,610

Across all tracked assignees

Innovation Score

27.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Allergan Holdings France S.a.s. hold?

Allergan Holdings France S.a.s. holds 6 US granted patents filed between 2016 and 2021, spanning 12 technology areas.

What is Allergan Holdings France S.a.s.'s Innovation Score?

Allergan Holdings France S.a.s. has an Innovation Score of 27.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Allergan Holdings France S.a.s. focus on?

Allergan Holdings France S.a.s.'s top technology area is A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES) with 5 patents. The company has filed patents in 12 CPC subclasses total.

Is Allergan Holdings France S.a.s.'s patent filing rate increasing or decreasing?

Allergan Holdings France S.a.s.'s recent filing velocity is -80% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Allergan Holdings France S.a.s.'s patents?

Allergan Holdings France S.a.s.'s patents average 14.5 claims each. This falls within the standard range, providing solid legal coverage.

How is the Allergan Holdings France S.a.s. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Allergan's 6 grants land it in the top 76% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Allergan ranks #38,610 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61L - see who else leads that technology area. A61L leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.